Symetryx Corp, 10% Owner at NeuBase Therapeutics, Inc. (NBSE), sold 410,774 shares at $1.80 ($669K) on 2023-09-07, disclosed to the SEC on 2023-09-11.
Open-market sale of $669k NBSE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 74,852 | $135K | 20.2% |
| 2 | $1.80 | 74,852 | $135K | 20.2% |
| 3 | $1.53 | 128,847 | $197K | 29.5% |
| 4 | $1.53 | 128,847 | $197K | 29.5% |
| 5 | $1.44 | 3,376 | $5K | 0.7% |
| Total | $1.63 avg | 410,774 |
| $669K |
| 100% |
| Filing → |